ACAD R&D Expense Growth
Acadia Pharmaceuticals Inc · R&D Expense Growth
ACAD R&D Expense Growth
Latest reported8.43%period ending
ACAD FY R&D Growth (YoY) (0.00% → 8.43%)
Latest values, visible window
High-resolution chart · PNG
ACAD r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 8.4264% | |
| -13.7564% | |
| -2.7535% | |
| 51.0244% | |
| -24.9788% | |
| 32.7579% | |
| 28.4362% | |
| 25.4536% | |
| 50.2649% | |
| 34.4055% | |
| 21.892% | |
| 126.7869% | |
| 42.1837% | |
| 8.5794% | |
| -15.89% | |
| -50.5134% | |
| -26.7225% | |
| -2.0572% | |
| 17.2962% | |
| 60.1336% | |
| 31.5255% | |
| 38.4942% | |
| 13.5% | |
| 13.9855% | |
| 34.56% | |
| 0% |